Economic Consequences of Not Recognizing Bipolar Disorder Patients: A Cross-Sectional Descriptive Analysis
The DOI matches its Crossref record.
Abstract
BACKGROUND: This retrospective study compared treatment patterns and costs for patients with recognized and unrecognized bipolar disorder with those of depressed patients without a bipolar disorder claim. METHOD: Claims data for 7 large national employers covering 585,584 persons aged less than 65 years were used to identify patients diagnosed with depression and initially treated with antidepressants. Data on employees, as well as spouses and dependents, for the period 1998 to mid-2001 were used. Patients were identified as bipolar based on the criteria of a bipolar diagnosis claim (ICD-9 codes: 296.0, 296.1, 296.4-296.8) and/or a mood stabilizer prescription claim. Of the patients identified as bipolar, unrecognized bipolar disorder (unrecognized-BP) patients met the criteria after antidepressant initiation, while recognized bipolar disorder (recognized-BP) patients met the criteria at or before initiation. The remaining patients in the sample were non-bipolar depressed (non-BP) patients. Outcome measures included treatment patterns and monthly medical costs in the 12 months subsequent to initiation of antidepressant treatment. RESULTS: Of the 9009 patients treated for depression with antidepressants, there were 8383 non-BP patients (93.1%), 293 recognized-BP patients (3.3%), and 333 unrecognized-BP patients (3.7%). Use of combination therapies varied among the non-BP (11%), unrecognized-BP (32%), and recognized-BP patients (44%) (all pairwise p <.01). Use of mood stabilizers was less frequent among unrecognized-BP patients (14%) than recognized-BP patients (34%) (p <.0001). Unrecognized-BP patients incurred significantly greater (p <.05) mean monthly medical costs ($1179 US dollars) in the 12 months following initiation of antidepressant treatment compared with recognized-BP patients ($801 US dollars) and non-BP patients ($585 US dollars). Monthly indirect costs were significantly greater (p <.05) for unrecognized-BP ($570 US dollars) and recognized-BP ($514 US dollars) employees compared with non-BP employees ($335 US dollars) in the 12 months following antidepressant initiation. CONCLUSIONS: Patterns of medication treatment for bipolar disorder were suboptimal. Accurate and timely recognition of bipolar disease was associated with lower medical costs and lower indirect costs due to work loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Self-citationIs Bipolar Disorder Overdiagnosed?
Zimmerman, M., Ruggero, C. J., Chelminski, I., & Young, D. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0608 · Cited by 230
Altamura, A. C., Buoli, M., Caldiroli, A., Caron, L., Cumerlato Melter, C., Dobrea, C., Cigliobianco, M., & Zanelli Quarantini, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.04.024 · Cited by 162
The economic burden of depression in the US: societal and patient perspectives
Greenberg, P. E., & Birnbaum, H. G. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.3.369 · Cited by 166
“In addition, Birnbaum [49] found that unrecognised bipolar patients (i.e., those diagnosed with depression and treated with antidepressants before initial bipolar diagnoses) incurred monthly medical costs ∼ 50% greater than those of recognised bipolar patients in the 12 months following initiation of antidepressant tr…”
BackgroundSelf-citationA population-based analysis of distinguishers of bipolar disorder from major depressive disorder
Schaffer, A., Cairney, J., Veldhuizen, S., Kurdyak, P., Cheung, A., & Levitt, A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.118 · Cited by 53
“Treatment strategies for BD and MDD differ considerably, and patients with BD that have been misdiagnosed as having MDD are significantly more likely to receive antidepressant medications, often as monotherapy, which can lead to mood instability and switching to mania (Birnbaum et al., 2003; Matza et al., 2005; Shi et…”
BackgroundResultInfluential
Metadata
- Authors
- Birnbaum, H. G., Shi, L., Dial, E., Oster, E. F., Greenberg, P. E., & Mallett, D. A.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2003-10-15
- Volume
- 64
- Issue
- 10
- Pages
- 1201-1209
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2052650828
- Cited by
- 99
- References
- 0
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Economic Consequences of Not Recognizing Bipolar Disorder Patients: A Cross-Sectional Descriptive Analysis. https://app.cochat.ai/papers/10.4088/jcp.v64n1010
- The paper
- Birnbaum, H. G., Shi, L., Dial, E., Oster, E. F., Greenberg, P. E., & Mallett, D. A. (2003). Economic Consequences of Not Recognizing Bipolar Disorder Patients: A Cross-Sectional Descriptive Analysis. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v64n1010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.